Longitudinal data revealed distinct epilepsy outcome trajectories
Source check: Source checked. Not independent scientific confirmation.
Finding: In 2,586 retrospectively followed epilepsy patients, the study identified five longitudinal trajectory clusters, including three associated with better and two with poorer outcomes. One poorer-outcome cluster had persistent high seizure burden and hippocampal sclerosis. Single-center retrospective data and internal evaluation do not establish prospective clinical benefit or external generalization.
Technology: Random forest, XGBoost, LightGBM, CatBoost, SAINT and HDBSCAN
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Supervised models predicted final seizure outcome and HDBSCAN clustered longitudinal clinical trajectories, linking learned analysis to the reported outcome subgroups.
- Test and result
- In 2,586 retrospectively followed epilepsy patients, the study identified five longitudinal trajectory clusters, including three associated with better and two with poorer outcomes. One poorer-outcome cluster had persistent high seizure burden and hippocampal sclerosis.
- Limitation / still unknown
- Single-center retrospective data and internal evaluation do not establish prospective clinical benefit or external generalization.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12660973/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Original full-text Methods and Results reviewed from the primary paper or preprint; first result-bearing version checked from the supplied source review; author affiliations checked against exact-DOI metadata where available..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.